A Bayesian adaptive design for cancer phase I trials using a flexible range of doses. Issue 3 (4th May 2018)

• Record Type: Journal Article
• Authors: Tighiouart, Mourad; Cook-Wiens, Galen; Rogatko, André
• Is Part Of: Journal of biopharmaceutical statistics. Volume 28:Issue 3(2018)
• Page Start: 562
• Page End: 574
• Publication Date: 2018-05-04
• Subjects: Cancer phase I trials -- dose-limiting toxicity -- escalation with overdose control -- flexible dose range -- maximum tolerated dose; Pharmacy -- Statistical methods -- Periodicals; Drugs -- Testing -- Statistical methods -- Periodicals; Biometry -- Periodicals; Biopharmaceutics -- Periodicals; Pharmacokinetics -- Periodicals; 615.19
• DOI: 10.1080/10543406.2017.1372774
• Languages: English
• ISSNs: 1054-3406

Abstract

ABSTRACT: We present a Bayesian adaptive design for dose finding in cancer phase I clinical trials. The goal is to estimate the maximum tolerated dose (MTD) after possible modification of the dose range during the trial. Parametric models are used to describe the relationship between the dose and the probability of dose-limiting toxicity (DLT). We investigate model reparameterization in terms of the probabilities of DLT at the minimum and maximum available doses at the start of the trial. Trial design proceeds using escalation with overdose control (EWOC), where at each stage of the trial we seek the dose of the agent such that the posterior probability of exceeding the MTD of this agent is bounded by a feasibility bound. At any time during the trial, we test whether the MTD is below or above the minimum and maximum doses, respectively. If during the trial there is evidence that the MTD is outside the range of doses, we extend the range of doses and complete the trial with the planned sample size. At the end of the trial, a Bayes estimate of the MTD is proposed. We evaluate design operating characteristics in terms of safety of the trial design and efficiency of the MTD estimate under various scenarios and model misspecification. The methodology is further compared to the original EWOC design. We showed by comprehensive simulation studies that the proposed method is safe and can estimate the MTD more efficiently than the original EWOC design.